Cover Image

Effectiveness of Class IC Antiarrhythmics in Patients with Paroxysmal Form of Atrial Fibrillation in Absence of Structural Heart Disease

Aim. To study the efficacy of class IC arrhythmic drugs (AAD) and catheter ablation (CA) for paroxysmal form of atrial fibrillation (AF) in patients with without structural heart disease.Material and methods. The study included 122 patients (44 men, 78 women, mean age 63 [55;68] years) with symptoma...

Full description

Saved in:

Bibliographic Details
Main Authors:	D. A. Tsaregorodtsev (Author), M. A. Khalikova (Author), S. S. Vasyukov (Author), M. M. Beraya (Author), A. V. Sedov (Author)
Format:	Book
Published:	Столичная издательская компания, 2023-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Predictors of class IC antiarrhythmic drugs efficacy in patients with paroxysmal form of atrial fibrillation
by: Manizha A. Khalikova, et al.
Published: (2023)

Tactics of Antiarrhythmic Therapy in Comorbid Elderly and Senile Patients with Paroxysmal and Recurrent Atrial Fibrillation
by: M. H. Fedorova, et al.
Published: (2018)

Efficacy of class III antiarrhythmics and magnesium combination therapy for atrial fibrillation
by: Wang A
Published: (2012)

Changes in Arterial Wall Stiffness in Patients with Obesity and Paroxysmal Form of Atrial Fibrillation
by: V. I. Podzolkov, et al.
Published: (2020)

PAROXYSMAL ATRIAL FIBRILLATION: CHOICE OF CARDIOVERSION THERAPY
by: B. A. Tatarskii
Published: (2015)

PAROXYSMAL ATRIAL FIBRILLATION: CHOICE OF CARDIOVERSION THERAPY
by: B. A. Tatarskii
Published: (2015)

Safety issues of antiarrhythmic therapy for atrial fibrillation
by: I.I. Reznik, et al.
Published: (2024)

Paroxysmal atrial fibrillation in cryptogenic stroke
by: Neha S Dangayach, et al.
Published: (2011)

ANTIARRHYTHMIC EFFICACY OF PROPAFENONE IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION
by: R. D. Kurbanov, et al.
Published: (2016)

ANTIARRHYTHMIC EFFICACY OF PROPAFENONE IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION
by: R. D. Kurbanov, et al.
Published: (2016)

Physical rehabilitation in idiopathic paroxysmal atrial fibrillation
by: O. D. Lebedeva
Published: (2020)

Present and future of antiarrhythmic therapy for atrial fibrillation: A review
by: Aida I. Tarzimanova
Published: (2024)

Antithrombotic Therapy in Patients with Paroxysmal Atrial Fibrillation after Catheter Treatment
by: O. R. Eshmatov, et al.
Published: (2023)

CHANGES IN THE LEVEL OF NATRIURETIC PEPTIDES IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMIC DRUGS
by: V. I. Podzolkov, et al.
Published: (2015)

CHANGES IN THE LEVEL OF NATRIURETIC PEPTIDES IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMIC DRUGS
by: V. I. Podzolkov, et al.
Published: (2015)

Electrophysiological Effects of the Class Ic Antiarrhythmic Drug Pilsicainide on the Guinea-Pig Pulmonary Vein Myocardium
by: Akira Takahara, et al.
Published: (2012)

An economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from a German healthcare payer perspective
by: Malte Kuniss, et al.
Published: (2024)

EFFECT OF SPIRAPRIL ON THE LENGTH OF INTERICTAL INTERVAL IN PAROXYSMAL ATRIAL FIBRILLATION
by: L. N. Chikhireva, et al.
Published: (2015)

EFFECT OF SPIRAPRIL ON THE LENGTH OF INTERICTAL INTERVAL IN PAROXYSMAL ATRIAL FIBRILLATION
by: L. N. Chikhireva, et al.
Published: (2015)

Antiarrhythmic Properties of Ranolazine: Inhibition of Atrial Fibrillation Associated TASK-1 Potassium Channels
by: Antonius Ratte, et al.
Published: (2019)

Racial and Ethnic Differences in Initiation and Discontinuation of Antiarrhythmic Medications in Management of Atrial Fibrillation
by: Kipp R, et al.
Published: (2024)

Paroxysmal Atrial Fibrillation Induced by Ciprofloxacin: A Rare Adverse Effect
by: Fatma Hammami, et al.
Published: (2020)

Effect of cryoballoon ablation parameters on recurrence in patients with paroxysmal atrial fibrillation
by: Abdullah Orhan Demirtaş, et al.
Published: (2019)

Antiarrhythmic Effect of Ranolazine in Combination with Selective NCX-Inhibition in an Experimental Model of Atrial Fibrillation
by: Julian Wolfes, et al.
Published: (2020)

FEATURES OF DAILY ECG MONITORING IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION AND ACCOMPANYING OBESITY
by: Yuriy Kovbasniuk
Published: (2015)

Pharmacological cardioversion of atrial fibrillation paroxysm in elderly and senile patients at prehospital stage
by: Andrei V. Syrov
Published: (2021)

Successful ablation of paroxysmal atrial fibrillation originating in left atrial appendage with single shot cryoballoon technique
by: Uğur Canpolat, et al.
Published: (2017)

Absence Epilepsy and Paroxysmal Dyskinesia
by: J Gordon Millichap
Published: (2002)

Revisiting Antiarrhythmic Drug Therapy for Atrial Fibrillation: Reviewing Lessons Learned and Redefining Therapeutic Paradigms
by: Meng Geng, et al.
Published: (2020)

Comparing monopharmacotherapy of antiarrhythmic and anticoagulant drugs with other drugs for atrial fibrillation: A complete review of clinical trials
by: Akshat D. Modi, et al.
Published: (2023)

PHARMACOEPIDEMIOLOGICAL ANALYSIS OF THE TREATMENT OF PAROXYSMAL AND PERSISTENT ATRIAL FIBRILLATION IN EVERY DAY CLINICAL PRACTICE
by: I. V. Graifer, et al.
Published: (2016)

Association of plasma fibronectin level with left atrial electrical and structural remodelling in lone paroxysmal atrial fibrillation: a cross-sectional study
by: Uğur Canpolat, et al.
Published: (2015)

Extracellular matrix change in patients with various forms of atrial fibrillation
by: A. V. Goryachiy, et al.
Published: (2017)

Extracellular matrix change in patients with various forms of atrial fibrillation
by: A. V. Goryachiy, et al.
Published: (2017)

Antiarrhythmic drug therapy after catheter ablation for atrial fibrillation-Insights from the German Ablation Registry
by: Ruben Schleberger, et al.
Published: (2021)

NEW ANTIARRHYTHMIC DRUG FOR THE TREATMENT OF ATRIAL FIBRILLATION. STUDY DATA, CLINICAL GUIDELINES, REGULATORY AGENCY RECOMMENDATIONS
by: S. Yu. Martsevich, et al.
Published: (2016)

Left Atrial Strain Helps Identifying the Cardioembolic Risk in Transient Ischemic Attacks Patients with Silent Paroxysmal Atrial Fibrillation
by: Arnăutu SF, et al.
Published: (2022)

CHANGE OF LOCAL MYOCARDIAL CONTRACTILITY DUE TO SELECTION OF DIFFERENT ARRHYTHMIA TREATMENT STRATEGIES IN PATIENTS WITH ISCHEMIC HEART DISEASE AND PAROXYSMAL ATRIAL FIBRILLATION
by: V. I. Podzolkov, et al.
Published: (2015)

CHANGE OF LOCAL MYOCARDIAL CONTRACTILITY DUE TO SELECTION OF DIFFERENT ARRHYTHMIA TREATMENT STRATEGIES IN PATIENTS WITH ISCHEMIC HEART DISEASE AND PAROXYSMAL ATRIAL FIBRILLATION
by: V. I. Podzolkov, et al.
Published: (2015)

Study of the Effect of Proton Pump Inhibitors on the Development of Hypomagnesemia in Patients with Paroxysmal Atrial Fibrillation on the Background of Autonomic Sinus Node Dysfunction
by: Ya. G. Bozhko, et al.
Published: (2020)